Suppliers / BrightGene Bio-Medical Technology
BrightGene Bio-Medical Technology
China 688166.SS 21 employees Updated 9 July 2026
BrightGene Bio-Medical Technology is an API manufacturer based in China. It holds 35 active US drug master files and 3 valid CEPs across a filed portfolio of 25 molecules.
3
filings
across 1 regulators
Registered plants
| Site | FDA FEI |
| Suzhou, China | Not on file |
What they file, and where
| Molecule | Regulators | Docs |
| Everolimus | EDQM, US FDA | 3 |
| Micafungin | US FDA | 3 |
| Posaconazole | US FDA | 3 |
| Dalbavancin | US FDA | 2 |
| Entecavir | EDQM, US FDA | 2 |
| Fidaxomicin | US FDA | 2 |
| Fondaparinux | US FDA | 2 |
| Oseltamivir | EDQM, US FDA | 2 |
| Pimecrolimus | US FDA | 2 |
| Saxagliptin | US FDA | 2 |
Show all 25 molecules on file
| (21R)-Argatroban | US FDA | 1 |
| Anidulafungin | US FDA | 1 |
| Carboprost | US FDA | 1 |
| Caspofungin | US FDA | 1 |
| Eribulin | US FDA | 1 |
| Exatecan | US FDA | 1 |
| Ferric Carboxymaltose | US FDA | 1 |
| Isavuconazonium | US FDA | 1 |
| Lurbinectedin | US FDA | 1 |
| Molnupiravir | US FDA | 1 |
| Pemetrexed | US FDA | 1 |
| Sirolimus | US FDA | 1 |
| Sugammadex | US FDA | 1 |
| Trabectedin | US FDA | 1 |
| Voclosporin | US FDA | 1 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| MINSA (CR) | 3 | None |
Comparing suppliers?
Choose your molecules and target markets. BrightGene Bio-Medical Technology comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability